WASHINGTON, October 23, 2026 , The Department of Health and Human Services released a coordinated Kidney Care National Plan this week that sets new federal priorities for preventing kidney disease, expanding patient choice in dialysis, and reforming the nation’s transplant system. The plan articulates policy directions intended to detect disease earlier, shift care toward less invasive and home-based treatments when safe, and hold organ procurement organizations to higher standards. H2: What the plan says and why it matters The Kidney Care National Plan lays out three central goals: prevent kidney failure before it begins, restore competition and patient choice in dialysis care, and reform organ transplantation and procurement. The plan builds on prior federal efforts to transform kidney care, and frames kidney disease as both a clinical and a health system challenge that drives substantial costs for patients and taxpayers. The federal government has financed the majority of kidney care since Medicare extended coverage for end stage renal disease in 1972. That longstanding role in financing makes federal policy a major lever for changing how care is delivered and paid for across the United States. HHS officials say the plan identifies where agencies can use regulation, payment changes, research and oversight to improve outcomes and access across the spectrum of kidney disease. H2: Early detection and prevention come to the fore A central emphasis is on detecting kidney disease earlier so clinicians can slow progression and reduce the number of people who reach kidney failure. The plan signals federal attention to screening and primary care interventions, aiming to shift investment from treating established kidney failure toward prevention and earlier-stage care. Advocates say that, if implemented, such a focus could reduce suffering and long term costs by catching treatable disease sooner. H2: More home dialysis and competition in the dialysis market The plan also prioritizes expanding home dialysis options and restoring competition in the dialysis market. For decades, in-center hemodialysis provided the bulk of life sustaining dialysis for people with kidney failure, often requiring patients to travel multiple times per week. Federal officials propose policies intended to increase patient access to home therapies and make it easier for new providers to enter the market. Provider groups and industry stakeholders broadly welcomed the goals on innovation and choice, but they stressed that changes will require operational work at the state and local level. Patient advocates have pointed to persistent geographic disparities in access to home dialysis and to the need for patient education and home support services for adoption of home modalities to be realistic and safe. H2: Transplant system overhaul and donor support The plan addresses the organ transplant system by proposing steps to strengthen accountability among organ procurement organizations and to reduce barriers to living donation. The plan refers to actions undertaken this year to revise donor reimbursement programs and streamline processes intended to reduce financial obstacles to donation. HHS officials framed transplantation as the optimal treatment for many people with kidney failure and called for reforms to increase access while strengthening patient safety. The federal focus on living donor reimbursement and procurement accountability responds to longstanding concerns that the transplant system has uneven performance across regions. The department underscored enforcement tools and oversight mechanisms it can use to address underperforming entities. H2: Reaction from patient groups and professional organizations Major kidney advocacy organizations responded to the plan with statements of conditional support on October 23, 2026. National patient groups welcomed the emphasis on prevention, transplantation and increased options for home dialysis, while urging Congress and federal agencies to provide funding and concrete rulemaking that translate the plan into measurable changes. Clinical societies noted opportunities in the plan but also called for careful evaluation, research and safeguards as new payment and regulatory pathways are developed. H2: Implementation will determine impact Experts and advocates say the plan represents an important federal vision, but that measurable improvements for patients will depend on implementation details. Many of the plan’s recommendations require subsequent rulemaking, funding allocations, or statutory changes. Observers also highlighted that federal action will need to be paired with local provider readiness, workforce capacity, and supports for patients who choose home therapies. For millions of Americans living with chronic kidney disease, the federal plan signals a shift in emphasis toward preventing progression and expanding treatment options beyond the dialysis center. Whether the plan reduces the number of people who reach kidney failure, increases access to transplants, and meaningfully lowers patient burdens will hinge on the next steps by agencies, Congress, and the kidney care community. H2: What to watch next In the weeks ahead, stakeholders will be watching for agency rulemaking, proposed payment changes and funding decisions that could put the plan into practice. Lawmakers and advocacy groups will likely press federal agencies for implementation timelines and specific investments to expand screening, support home dialysis infrastructure, and reform transplant oversight. The HHS Kidney Care National Plan, announced broadly on October 20 and discussed in further federal communications and stakeholder responses on October 23, 2026, frames a policy agenda that could reshape how the United States prevents and treats kidney disease if the vision is translated into durable programs and funding.